Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,398,000
+2,000 (0.14%)
At close: Sep 18, 2026
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 64.64 trillion as of September 18, 2026. Its market cap has decreased by -10.96% in one year.
Market Cap
64.64T
Enterprise Value
63.67T
Revenue
5.12T
Ranking
n/a
PE Ratio
32.93
Stock Price
1,398,000.00
ChartMarket Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 64.64T, an increase of 578.47%. That is a compound annual growth rate of 21.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 64.64T | -17.61% |
| Dec 30, 2025 | 78.46T | 16.17% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 42.53T |
| ALTEOGEN | 17.79T |
| Samsung Epis Holdings | 8.12T |
| SK Biopharmaceuticals | 6.12T |
| HLB Co., Ltd. | 4.24T |
| Peptron | 3.42T |
| ABL Bio | 3.24T |
| LigaChem Biosciences | 3.04T |